
For some time the medical treatment of glaucoma has consisted of topical zzso zzso agents, zzso and oral zzso zzso zzso zzso However, the therapeutic arsenal available for the medical treatment of glaucoma has recently extended with new classes of zzso zzso agents zzso zzso local zzso and zzso zzso zzso are still the mainstay in glaucoma treatment and are first line zzso However, even if they are applied once daily, as with zzso in gel forming solution and zzso the possible zzso adverse effects of zzso remain a cause for zzso When zzso with zzso is ineffective in reducing zzso pressure zzso or is hampered by adverse effects, a change of zzso to zzso local zzso zzso zzso zzso or to zzso zzso is zzso zzso local zzso and zzso zzso such as zzso may in time become first line drugs because they reduce zzso effectively and until now systemic adverse effects have rarely been reported with these zzso The development of a zzso of either a local zzso or an zzso zzso with a sustained and continuous effect on zzso level, which could be applied once a day is zzso Because of these new developments, zzso zzso zzso and zzso are recommended as second or third line zzso The zzso zzso are considered third line drugs as better agents with fewer local and systemic adverse effects have become zzso zzso zzso may be used temporarily in patients with elevated zzso zzso zzso or zzso or continuously in patients with glaucoma resistant to other zzso Combining zzso zzso drugs is indicated when the target pressure for an individual patient cannot be reached with zzso Combination therapy of zzso is additive with zzso topical zzso and zzso zzso such as zzso can be combined with zzso zzso agents, local zzso and zzso zzso with zzso or local zzso need further zzso Treatment of glaucoma with the new zzso zzso agents, either in zzso or combination therapy, may provide lower zzso and delay or postpone the need for zzso 

